- Tuesday Morning Corp. stock price today and history
Tuesday Morning Corp. (TUES) stock prices updated...
Please, Signup (Login) to subscribe or trade (demo)
Tuesday Morning Corp. stock price
Tuesday Morning Corp. latest news:
Why Citigroup Won't Miss That $22 Billion
Citigroup(C) Inc. on Tuesday posted one of its largest quarterly losses ever, dragged down by a $22 billion write-down related to the recently passed tax overhaul. This helped its shares to rise by around 1% in morning trading. No, this isn't "opposite day."
Ciena stock rises after Goldman Sachs upgrades to buy
Shares of telecom equipment supplier Ciena Corp. rose 3.2% in Tuesday morning trading following an upgrade to buy from analysts at Goldman Sachs. "We view Ciena as a key beneficiary of a more bullish
outlook on US carrier capital expenditures, improving competitive environment, and a lower bar of expectations as investors adjust to an environment of decelerating optical market growth," wrote the analysts, led by Doug Clark. Ciena has heavy exposure to AT&T and Verizon, he wrote. Stein thinks that tax reform and 5G investments could also provide a boost to the stock. Ciena shares have lost 7.5% in the past 12 months, while the S&P 500 has gained 23%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Nvidia stock rises after analysts praise automotive opportunities
Nvidia Corp. shares are up 2% in Tuesday morning trading after a pair of analysts expressed their optimism about the company. "Despite our view that 2018 will be a year of growing pains for semis, Nvidia's strength in AI today, and autonomous driving in the future, make it the king of this jungle in our view," wrote SunTrust Robinson Humphrey analyst William Stein. He's impressed with the company's recently announced partnerships with companies in the automotive space, including Volkswagen and Uber. "While autonomous driving technology was the hottest topic at the [CES] event, we also noticed that much of the discussion centered around co-pilot technology, including the Nvidia-powered Volkswagen ID Buzz," Stein wrote. He also likes the in-car infotainment system that Nvidia designed for Mercedes, as well as the company's discussion of its first Drive Xavier processors. Separately, analysts at Mizuho raised their price target on shares to $240 from $225, also citing automotive opportunities. Nvidia shares have gained 119% in the past 12 months, compared with a 23% rise for the S&P 500 Index and a 45% gain for the Philadelphia Semiconductor Index .Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Qualcomm stock rises after Instinet upgrades to buy
Shares of Qualcomm Inc. rose 2.9% in Tuesday morning trading after analysts at Instinet upgraded the stock to buy from neutral. The analysts, led by Romit Shah, believe that Broadcom Ltd.'s attempt at a hostile takeover will light a fire under a management team they consider having been "unassertive" at times. "We expect the company to more aggressively focus on driving shareholder value in order to remain a standalone franchise," Shah wrote, including by closing the acquisition of NXP Semiconductors . He added that, while "not necessarily an immediate catalyst," Qualcomm might also consider settling its legal battle with Apple Inc. . "This would likely come as the strongest counter to Broadcom's attempt to buy the company," Shah wrote. Qualcomm also gave an overview of its 2017 financials in a filing released Tuesday. The company said it generated $23.2 billion in non-GAAP revenue for the year, above the FactSet consensus estimate of $22.8 billion. The company also sent a letter to shareholders asking them to reject Broadcom's takeover bid. Qualcomm shares have gained 4.6% so far this year, compared with a 4.9% rise for the S&P 500 Index and a 6.8% gain for the Philadelphia Semiconductor Index .Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Amazon stock rises after BMO raises price target to new Street high
Shares of Amazon.com Inc. gained 1.8% in Tuesday morning trading after analysts at BMO Capital Markets raised their price target on shares to $1,600, the highest among analysts tracked by FactSet. The analysts, led by Daniel Salmon, are upbeat about Amazon's advertising opportunities and believe that the ad business represents an $18 billion total addressable market "in the midterm." He thinks Amazon could eventually generate 22% of its total gross merchandise value from direct response ads. Separately, analysts at Oppenheimer raised their price target to $1,450 and named Amazon their "top large-cap pick" for the year. "Amazon is best positioned among our large-cap universe to benefit from secular trends - shift to e-commerce, public cloud, automation and digital advertising - further supported by an improving global macroeconomic backdrop and domestic tax reform," wrote the analysts, led by Jason Helfstein. Amazon shares have gained 11.6% so far this year, compared with a 4.8% gain for the S&P 500 Index .Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Could Iran protests spark rise in oil prices?
Oil prices edged toward levels not seen since mid-2015 on Tuesday morning after Iran protests conjured speculation about geopolitical instability.
Oracle falls after report that Amazon, Salesforce are developing own databases
Oracle Corp. shares declined Tuesday after a report that Amazon.com Inc. and Salesforce.com Inc. are looking to end their respective deals for Oracle database software. The Information reported that Amazon and Salesforce are both developing their own internal solutions that will allow them to stop using Oracle's ubiquitous database offering, according to anonymous sources. While Amazon and Salesforce are customers of Oracle, they are rivals as well, especially with Amazon moving more into enterprise software through its Amazon Web Services segment, and Oracle co-founder Larry Ellison has targeted both in barbed comments, with Amazon in special focus as of late. The Information reported that Salesforce's internal database was code-named "Sayonara," Japanese for goodbye, and that Amazon called one of its database products "RedShift" in reference to Oracle. Oracle stock was trading about 1% higher Tuesday morning before the report hit, but shares dropped to a daily loss of about 0.7% after the news hit.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Stitch Fix stock jumps to new all-time high
Shares of Stitch Fix Inc. jumped 10.3% in Tuesday morning trading, to reach a new all-time intraday high. Tuesday's rally more than makes up for share price losses incurred last week after the company reported its first quarterly earnings as a public company. The online clothing retailer went public in mid-November, and shares are up 82% from their IPO price of $15. The S&P 500 is up 4% since Stitch Fix's IPO. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Carnival's Q4 Earnings Lift Cruise Stocks
Shares of Carnival Corporation CCL jumped on Tuesday morning after the company reported better than expected fourth quarter 2017 earnings helping lift the rest of the cruise industry including Norwegian Cruise Line NCLH and Royal Caribbean RCL Carnival reported adjusted Q4 earnings of 0
Square stock falls after Morgan Stanley cites 'balanced' risk/reward
Shares of Square Inc. fell 0.8% in Tuesday morning trading after analysts at Morgan Stanley reiterated their equal-weight rating but raised their price target from $26 to $40. The analysts, led by James Faucette, model Square's revenue growing by 36% annually through 2020, above consensus figures. Faucette sees room for upside if Square has better-than-expected success moving upmarket, to larger sellers, but he notes that there are also a number of potential downsides. These include the possibility of volatility in the credit markets, which could hurt Square Capital, the company's lending business, as well as the potential for larger players to adopt more competitive pricing, which could limit further share gains for Square. "A narrowing gap between the base case and bull case limits further upside and keeps risk/reward balanced," he wrote. Shares have gained 175% so far this year, compared with a 20% rise for the S&P 500 Index . Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
24-hour flash sale: JetBlue fares as low as $39 one way; routes limited
JetBlue rolled out a 24-hour flash sale Tuesday morning that dropped round-trip fares below $150 on dozens of the carrier’s non-stop routes.
AMD, Nvidia stocks fall as analyst says AI will need different chips in 2018
Shares of Advanced Micro Devices Inc. and Nvidia Corp. fell 1.7% and 1.3%, respectively, in Tuesday morning trading, after analysts at Susquehanna suggested that application-specific integrated circuits (ASICs) could become more important than graphics processing units (GPUs) for 2018. "Nvidia was in the right place at the right time," wrote the analysts, led by Christoper Rolland, as its GPUs made for gaming purposes proved useful for complex artificial-intelligence tasks as well. "However, our discussions with numerous thought leaders in the industry suggest ASICs may replace much of today's GPU infrastructure over time," he added. Plus, GPUs could become less useful for the mining of cryptocurrencies in 2018, according to Rolland. AMD shares have fallen 12% so far in 2017, compared with an 80% gain for Nvidia shares. The S&P 500 is up 19% this year, while the Philadelphia Semiconductor Index has gained 37%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Imperva stock falls after JP Morgan downgrades to underweight
Shares of security-software firms Imperva Inc. , Check Point Software Technologies Ltd. , and Fortinet Inc. fell 3.5%, 0.3%, and 0.1%, respectively, in Tuesday morning trading, after analysts at JP Morgan downgraded the stocks. The analysts, led by Sterling Auty, now rate Imperva at underweight and both Check Point and Fortinet at neutral. Auty points to "sales execution issues" for Check Point and Imperva; he thinks it's unlikely that Check Point will go back to "winning consistent market share" and worries about the web-application firewall aspect of Imperva's business. Fortinet, meanwhile, has seen "turnover in the sales and marketing ranks" that has been weighing on results, Auty wrote. He noted that market-research firm Gartner now predicts core security spending to grow at a 6% annual clip through 2021, below a previous forecast for 6.5% growth. Imperva shares have risen 4.7% so far in 2017, compared with 40% and 25% rises for Fortinet and Check Point respectively. The S&P 500 is up 19% this year.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Verizon stock jumps toward 11-month high after Instinet upgrade
Verizon Inc. shares surged 1.9% in Tuesday morning trading, putting them on course to close at the highest level since January, after analysts at Instinet upgraded the stock to buy from neutral. "Better visibility into subscriber growth, rising average revenue per user, and cost control fuels our confidence earnings per share growth will resume in 2018," wrote the analysts, led by Jeffrey Kvaal. He believes the company, which announced a new streaming arrangement with the NFL on Monday, could launch an over-the-top streaming service by the end of the year and has some advantages over its peers in doing so. "Unlike AT&T it need not bundle to reduce churn or be overly mindful of its existing video base as its pay-TV base is minimal relative to rivals," he wrote. The firm raised its price target on Verizon shares to $61, from $47. Verizon's stock has fallen 1.3% so far in 2017, compared with a 19% gain for the S&P 500 .Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Asian markets extend losses after dismal session on Wall St
U.S. stock indexes held steady in Tuesday morning trading as some of the year's biggest winners picked themselves back up following recent stumbles.
UPDATE: Revance stock surges and Allergan drops on positive results for wrinkle injection
Revance Therapeutics Inc. shares surged nearly 38% in extremely heavy morning trade Tuesday after the company reported positive results for its wrinkle-relaxing injection in two late-stage clinical trials. If approved, the product, DaxibotulinumtoxinA for Injection (RT002), would be the first of its kind to last six months. Products currently on the market, including Allergan's market-leading Botox, last three to four months. Allergan shares dropped 3.2% in extremely heavy morning trade on Tuesday. In two trials, Revance's product showed highly statistically significant improvement relative to the placebo in reducing frown lines or wrinkles between eyebrows. The product is also being tested in a long-term safety trial, with results expected in the second half of next year; if the trial is successfully completed, Revance expects to file for approval in the first half of 2019 and, if it's approved, launch the product in the U.S. in 2020. Botox has been a wildly profitable product for Allergan, since patients largely pay out-of-pocket for it, and analysts have noted that new rivals could pose a long-term risk for the company. Revance's latest data are "better than their Ph 2 on several metrics," said EvercoreISI analyst Umer Raffat. But, with regard to being able to claim six months of effectiveness, Raffat said, "I think there's a case to be made for that, but that's not a layup." Raffat also noted that the product would likely be priced higher than Botox. In a statement to MarketWatch, Allergan called the Revance results "underwhelming." "Allergan does not expect Revance's toxin to enter the market until mid-2020, and we do not believe this data will support a longer duration claim," a company spokesperson said, adding that "based on the profile demonstrated in this data, Allergan does not view this toxin as being differentiated from Botox." Revance shares have surged 45.5% over the last three months to $35.80, compared with a 7.4% rise in the S&P 500 and a 11.7% rise in the Dow Jones Industrial Average .Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Bounceback for tech stocks helps push US indexes higher
U.S. stock indexes held steady in Tuesday morning trading as some of the year's biggest winners picked themselves back up following recent stumbles.
Nikkei falls hit by tech shares, offsets gains in financials
TOKYO, Dec 5 (Reuters) - Japan's Nikkei share average
dropped on Tuesday morning with semiconductor equipment
manufacturers' stocks hit by weakness in U.S. tech shares
overnight, undercutting gains in financial stocks as banks and
CBS News fires Charlie Rose after sex harassment allegations
CBS News said on Tuesday it had fired Charlie Rose, one of the most prominent American interviewers, the day after the Washington Post reported the television host had sexually harassed eight women. Rose was a co-host on the morning show "CBS This Morning" and a correspondent for its long-running Sunday night news magazine "60 Minutes."
SendGrid prices IPO above range, will sell more shares
SendGrid Inc. priced its initial public offering higher than expected and will offer more shares than originally planned, which will lead the email-marketing company to a total take of at least $131 million. SendGrid, which sells a software platform that helps companies manage email communications with customers, announced Tuesday evening that it will sell 8.2 million shares at $16 apiece. The 8-year-old startup had previously planned to sell 7.7 million shares at a price of $13.50 to $15.50 a share. Underwriting banks, led by Morgan Stanley and JP Morgan, have access to another 1.23 million shares that could be sold and push the total take higher. SendGrid is on track to report $100 million in annual revenue for the first time this year, and is approaching profitability after raising more than $80 million in venture investment. Shares are expected to begin trading Wednesday morning on the New York Stock Exchange.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Nikkei edges up in choppy trade; tech shares gain
TOKYO, Nov 14 (Reuters) - Japan's Nikkei share average edged
up on Tuesday morning in choppy trade, with semiconductor
equipment makers attracting buyers, while Mizuho Financial Group
fell on dismal earnings.
Losses for banks and smaller companies take US stocks lower
U.S. stocks edged higher Tuesday morning as health care companies and banks made modest gains.
Biogen stock drops 7% on concerns about Spinraza revenue growth
Biogen Inc. shares plummeted as much as 7% in extremely heavy Tuesday morning trade after Wall Street analysts raised questions about revenue growth for rare disease therapy Spinraza. Though sales of the spinal muscular atrophy therapy came in above analyst expectations, or $271 million compared with the FactSet consensus of $253 million, U.S. sales for the drug barely budged, coming in at $198 million compared with $195 million in the second quarter. (Spinraza was approved late last year.) Mizuho analyst Salim Syed described the growth as "flattish." However, because of $30 million of revenue build in the second quarter, "U.S. sales were not really flat," said Bernstein analyst Ronny Gal. "Our estimate is the rate of new US starts will be relatively stable and this will drive slight but limited US growth," Gal said, adding that it's likely that site capacity is slowing down new starts at existing sites. Biogen's shares declined in Tuesday trade despite reporting third-quarter profit and revenue beats, which EvercoreISI analyst Umer Raffat said "seems a bit overdone to me." Biogen management described Spinraza as a "key current and future growth driver" during its Tuesday third-quarter earnings call. "We expect that Spinraza continues on a strong trajectory in terms of patient uptake in the U.S. and internationally," said Biogen Chief Executive Michel Vounatsos, according to the FactSet earnings transcript. "However, due to the impact of the dosing scheduling, we anticipate Spinraza revenue growth in Q4 will be mostly driven by ex-U.S. markets." Biogen shares have surged 8.9% over the last three months, compared with a 4% rise in the S&P 500 .Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Tenet stock declines on CEO's earlier-than-expected departure
Tenet Healthcare Corp.(THC) shares declined 1.8% in Tuesday morning trade after the company's chief executive officer left the company at an earlier-than-expected date. The company announced in late August that then-Chief Executive Trevor Fetter would step down from his position and a director role either March 15 or when a successor was appointed. However, Fetter stepped down before a permanent successor was appointed.
Turtle Beach CorporationHEAR
Tuttle Tactical Management Multi-Strategy Income ETUTI
Tuttle Tactical Management U.S. Core ETFTUTT
Twenty-First Century Fox, Inc.FOX
Twenty-First Century Fox, Inc.FOXA
Twin Disc, IncorporatedTWIN
Two River BancorpTRCB
U S Concrete, Inc.USCR
U.S. Auto Parts Network, Inc.PRTS